Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman Sells 6,751 Shares of Stock

Dolby Laboratories (NYSE:DLB) CEO Kevin Yeaman sold 6,751 shares of Dolby Laboratories stock in a transaction dated Wednesday, December 17th. The shares were sold at an average price of $67.24, for a total value of $453,937.24. Following the completion of the sale, the chief executive officer directly owned 98,377 shares in the company, valued at approximately $6,614,869.48. This represents a 6.42% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Dolby Laboratories Price Performance

Dolby Laboratories stock traded up $0.33 during mid-day trading on Thursday, hitting $67.47. 21,754 shares of the company’s stock traded hands, compared to its average volume of 469,252. The stock has a market cap of $6.44 billion, a price-to-earnings ratio of 25.66 and a beta of 0.89. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66. The firm has a 50 day simple moving average of $66.88 and a two-hundred day simple moving average of $71.25.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Tuesday, November 18th. The electronics maker reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.70 by $0.29. The business had revenue of $307.02 million during the quarter, compared to analysts’ expectations of $305.76 million. Dolby Laboratories had a net margin of 18.90% and a return on equity of 11.99%. The business’s revenue was up .7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.61 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.190-4.340 EPS and its Q1 2026 guidance at 0.790-0.940 EPS. On average, research analysts anticipate that Dolby Laboratories will post 2.94 earnings per share for the current fiscal year.

Dolby Laboratories Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 10th. Stockholders of record on Tuesday, December 2nd were paid a $0.36 dividend. The ex-dividend date of this dividend was Tuesday, December 2nd. This is a positive change from Dolby Laboratories’s previous quarterly dividend of $0.33. This represents a $1.44 annualized dividend and a dividend yield of 2.1%. Dolby Laboratories’s payout ratio is currently 54.75%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on DLB. Robert W. Baird started coverage on shares of Dolby Laboratories in a research report on Friday, September 5th. They set a “neutral” rating and a $74.00 price target on the stock. Rosenblatt Securities decreased their price objective on Dolby Laboratories from $95.00 to $85.00 and set a “buy” rating for the company in a report on Wednesday, November 19th. Barrington Research cut their price target on shares of Dolby Laboratories from $100.00 to $95.00 and set an “outperform” rating on the stock in a report on Wednesday, November 19th. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, November 22nd. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Monday. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $92.00.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of DLB. MAI Capital Management lifted its holdings in Dolby Laboratories by 87.1% in the first quarter. MAI Capital Management now owns 348 shares of the electronics maker’s stock worth $28,000 after buying an additional 162 shares during the period. First Horizon Corp bought a new stake in shares of Dolby Laboratories in the third quarter worth $25,000. Hantz Financial Services Inc. grew its position in Dolby Laboratories by 166.7% during the third quarter. Hantz Financial Services Inc. now owns 352 shares of the electronics maker’s stock valued at $25,000 after buying an additional 220 shares during the period. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Dolby Laboratories in the 1st quarter worth $29,000. Finally, Allworth Financial LP raised its stake in shares of Dolby Laboratories by 590.4% in the second quarter. Allworth Financial LP now owns 504 shares of the electronics maker’s stock worth $37,000 after buying an additional 431 shares during the period. Hedge funds and other institutional investors own 58.56% of the company’s stock.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.